L-006,235 is primarily utilized in research settings as a potent and selective inhibitor of histone deacetylase 6 (HDAC6). Its application is significant in studying the role of HDAC6 in various cellular processes, including protein aggregation, cell motility, and stress response. Researchers employ L-006,235 to explore its potential therapeutic effects in diseases where HDAC6 dysregulation is implicated, such as cancer, neurodegenerative disorders, and inflammatory conditions. Additionally, it serves as a valuable tool in understanding the mechanisms of HDAC6 inhibition and its impact on cellular pathways, aiding in the development of targeted therapies.